e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Epidemiology of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Plasma MMP-9 is related to a bronchitic COPD phenotype–report from the obstructive lung disease in northern Sweden (OLIN) studies
R. Linder, A. Blomberg, J. Pourazar, A. F. Behndig, E. Rönmark, B. Lundbäck, A. Lindberg (Umea, Gothenburg, Sweden)
Source:
Annual Congress 2013 –Epidemiology of respiratory disease
Session:
Epidemiology of respiratory disease
Session type:
Thematic Poster Session
Number:
4197
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Linder, A. Blomberg, J. Pourazar, A. F. Behndig, E. Rönmark, B. Lundbäck, A. Lindberg (Umea, Gothenburg, Sweden). LATE-BREAKING ABSTRACT: Plasma MMP-9 is related to a bronchitic COPD phenotype–report from the obstructive lung disease in northern Sweden (OLIN) studies. Eur Respir J 2013; 42: Suppl. 57, 4197
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
LATE-BREAKING ABSTRACT: Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: The copenhagen general population study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
LATE-BREAKING ABSTRACT: Stratification of patients with COPD by frequence of exacerbations is an essential step for what to treat in COPD. - A survey in a real life COPD population
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
LATE-BREAKING ABSTRACT: Effects of rare SERPINA1 variants on emphysema and airtrapping in SPIROMICS
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
LATE-BREAKING ABSTRACT: Biomarkres in exacerbations of chronic obstructive pulmonary disease (ECOPD)
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
COPD prevalence in Austria: results from the Burden of obstructive lung disease (BOLD) study
Source: Eur Respir J 2006; 28: Suppl. 50, 446s
Year: 2006
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept